ANALYSIS: The latest NZX listing is well-timed to benefit from investor exuberance.
The retailer has shown its qualities over the years but can it get big in Australia?
Normalised numbers obscure the real performance of its high roller business.
The temptation to use that power will be great.
The regulator is showing much-needed leadership for our long-term security.
There were no shocking revelations but the regulators still managed to hit the mark.
PGG Wrightson’s departing chairman leaves a dubious legacy.
The government’s response is political posturing.
The biggest failure of Orion Health was its excessive float valuation.
Court’s rejection of merger opens way for necessary change in strategy.